Results for 'Adalimumab'

Order:
  1. The case of psoriatic arthritis developed periorbital infection following adalimumab therapy.Tuba Tülay Koca & Gülbahar Saraç - 2014 - European Journal of Therapeutics 20 (4):323-327.
    Psoriatic arthritis is a chronic, systemic inflammatory disorder. It has been classified in spondyloarthropathies group which shares clinical, radiologic, serologic features, familial and genetic relationship. Up to 5-30% of patients with psoriasis may go on to develop psoriatic arthritis, usually within 5-10 years. Adalimumab (ADA) is the first human monoclonal antibody against TNF-α. ADA is a biologic agent effective in both skin lesions and joint signs. Anti-TNF agents are powerful immunmodulating drugs with potentially side effects. Our case is 38 (...)
    Download  
     
    Export citation  
     
    Bookmark